Lantheus today said it appointed Paul Blanchfield as chief commercial officer, effective immediately.
Blanchfield will report to president and CEO Mary Anne Heino.
“With his extensive operational experience and deep expertise in commercializing rare disease products, Paul will be a valuable addition to our executive leadership team as we execute our long-term growth strategy,” Heino said in a news release.
Get the full story on our sister site, Drug Delivery Business News.